Government urged to promote genetic substitution

Korea needs to push up with a new prescription plan, under which doctors will be required to prescribe the active ingredient instead of the name of a specific drug product as they do now, according to the incumbent Korean Pharmaceutical Association (KPA) president Cho Chan-whi.

After winding up his recent European visit to participate in the general meeting of the International Pharmaceutica...